Last edition
News about "Verve Therapeutics"
Lilly Completes Acquisition of Verve Therapeutics
Eli Lilly and Company has completed its acquisition of Verve Therapeutics, a Boston-based clinical-stage firm developing genetic medicines for cardiovascular disease.
Verve Therapeutics | 26/07/2025 | By Mrinmoy Dey | 122
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members